Status:
COMPLETED
the Effect of High Dose Ascorbic Acid on Critically Ill Patients With ARDS
Lead Sponsor:
Misr International University
Conditions:
Acute Respiratory Distress
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
1. To access role of vitamin C supplementation in ARDS patients on the following: Oxidants/ antioxidants imbalance Length of hospital stay Mortality rate Weaning from mechanical ventilator Inciden...
Detailed Description
Acute Respiratory distress syndrome (ARDS) is a form of severe hypoxemic respiratory failure due to severe impairment of gas exchange and lung mechanics that is characterized by inflammatory injury to...
Eligibility Criteria
Inclusion
- All ARDS cases presenting to the Chest department ICU within 48 hours of diagnosis
- who don't have an exclusion criteria will be included.
Exclusion
- Known allergy to Vitamin C
- Inability to obtain consent;
- Age \< 18 years;
- More than 48 hours since meeting ARDS criteria;
- Pregnancy or breast feeding,
- Moribund patient not expected to survive 24 hours;
- Patients not eligible to CPR
- Active kidney stone
Key Trial Info
Start Date :
July 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 20 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03780933
Start Date
July 5 2017
End Date
June 20 2019
Last Update
October 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Embaba Chest Hospitals
Cairo, Egypt